Evaluation of cerebrospinal fluid levels of VAMP-2 and SNAP-25 in a dementia with Lewy bodies clinical cohort stratified by Alzheimer’s pathophysiological biomarkers

Abstract Background Synaptic protein levels in cerebrospinal fluid (CSF) may represent much-needed objective biomarkers of cognitive impairment, disease progression and drug efficacy in patients with dementia with Lewy bodies (DLB). Soluble N-ethylmaleimide-sensitive factor attachment proteins recep...

詳細記述

保存先:
書誌詳細
出版年:Alzheimer’s Research & Therapy
主要な著者: Alba Cervantes González, Julie Goossens, Elena Vera Campuzano, Isabel Sala, M. Belén Sánchez-Saudinós, Íñigo Rodríguez-Baz, Laia Lidón, Danna Perlaza, Alexandre Bejanin, Annakaisa Haapasalo, Juan Fortea, Daniel Alcolea, Alberto Lleó, Eugeen Vanmechelen, Olivia Belbin
フォーマット: 論文
出版事項: BMC 2025-02-01
主題:
VAMP-2
SNAP-25
Dementia with Lewy bodies
Synapse
Cerebrospinal fluid
Biomarker
オンライン･アクセス:https://doi.org/10.1186/s13195-025-01685-y
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

インターネット

https://doi.org/10.1186/s13195-025-01685-y

類似資料